Furthermore, our results confirmed CK7-negative and corresponding somatostatin receptor-positive status in challenging diagnostic subgroups, including tumors of unknown origin, post-chemo-radiotherapy patients, and high-grade neoplasia. The gene discussed is KRT7; the disease is neoplasm.